
    
      This will be an open label, non randomized, interventional pilot study evaluating the plasma
      and skin levels of minocycline in 10 subjects with moderate to severe acne vulgaris. Subjects
      with non inflammatory acne of nodular acne will not be enrolled. Subjects will be on an oral
      extended release minocycline regimen of up to 2mg/kg once a day for 4 weeks.

      Steady state levels of minocycline in plasma and skin will be determined.
    
  